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Abstract 
Purpose: To investigate the anti-diabetic potential of Picralima nitida leaf extracts in vitro. 
Methods: The current study evaluated the anti-diabetic potential of Picralima nitida leaf via in vitro 
inhibition of α-amylase and α-glucosidase using the acetone, water and ethanol extracts. Preliminary 
phytochemical analysis was performed on the acetone, aqueous and ethanol extracts of Picralima nitida 
leaf. The α-amylase inhibitory potentials of the extracts were investigated by reacting different 
concentrations of the extracts with α-amylase and starch solution while α-glucosidase inhibition was 
determined by pre-incubating α-glucosidase with different concentrations of the extracts followed by the 
addition of p-nitrophenylglucopyranoside (pNPG). The mode(s) of inhibition of both enzymes was 
determined using Lineweaver-Burke plot.  
Results: The acetone extract of Picralima nitida displayed the most effective inhibition of both α-
amylase and α-glucosidase activities with half-maximal inhibitory concentration (IC50) of 6.50 and 3.00 
mg/ml, respectively.  The results also showed that the extracts contain both non-competitive and 
competitive inhibitors of α-amylase and α-glucosidase respectively. The results of phytochemical 
analysis of the extract revealed the presence of saponins, flavonoids, tannins, terpenoids and reducing 
sugars. 
Conclusion: The observed inhibitions of α-amylase and α-glucosidase suggest that the leaf extracts of 
P. nitida may be useful in the management of diabetes mellitus. This buttresses the traditional use of P. 
nitida for the management of sugar-related disorders in some parts of Nigeria.  
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Diabetes mellitus is a complex disease 
characterized by gross derangement in 
carbohydrate, fat and protein metabolism due to 
deficiency in insulin secretion and/or action [1]. 
Mammalian α-amylase is a prominent enzyme in 
the pancreatic juice which breaks down large and 
insoluble starch molecules into absorbable 
molecules ultimately maltose [2]. α-glucosidase, 
on the other hand, anchored in the mucosal 
brush border of the small intestine catalyzes the 
end step of digestion of starch and disaccharides 
that are abundant in human diet [3]. Inhibitors of 
α-amylase and α-glucosidase delay the 
breakdown of carbohydrate in the small intestine 
and decrease the postprandial blood glucose 
excursion levels in diabetic patients [4]. The 
inhibition of these two prominent enzymes has 
been found as a useful and effective strategy to 
lower the levels of postprandial hyperglycemia 
[6]. The incidence of diabetes mellitus in the 
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world is increasing at an alarming rate, affecting 
close to 5 % of its population [5]. 
 
Picralima nitida (Staph) (Apocynaceae) 
otherwise known as Akuama or ‘Abeere’ among 
the Yoruba speaking people of South-Western 
Nigeria, is a medicinal plant with diverse uses [7]. 
It is used in traditional medicines in the treatment 
of inflammation, otitis, pulmonary bronchitis, 
venereal diseases, various fevers, hypertension, 
jaundice, gastrointestinal disorders and malaria 
[8, 9]. Previous studies have shown that the 
extracts from its seeds, fruit rind and stem bark 
possess antimicrobial, anti-inflammatory, 
antipyretic, anti-trypanosomal, anti-plasmodial 
[10], anti-leishmanial, larvicidal [11] and 
hypoglycaemic potentials [12].  
 
Although several studies have been conducted 
on the biological and pharmacological potentials 
of Picralima nitida, there is no report on its effect 
on α-amylase and α-glucosidase activities in vitro 
Yet the species is used in the traditional 
management of sugar-related disorders in 
Nigeria. The objective of this study, therefore, 
was to evaluate the α-amylase and α-
glucosidase inhibitory potentials of Picralima 




Plant material  
 
The leaves of Picralima nitida were obtained 
from Ikoga-Zebbe village, Badagry Local 
Government Area of Lagos State, Nigeria in May 
2012, and authenticated by Dr AB Kadiri of the 
Department of Botany, University of Lagos, 
Nigeria. A voucher specimen (LUH 4725) was 
deposited in the University herbarium of the 
Department of Botany, University of Lagos.  
 
Chemicals and reagents  
 
α-Amylase from Aspergillus oryzae, α-
glucosidase from Saccharomyces cerevisiae and 
para-nitrophenyl-glucopyranoside were products 
of Sigma-Adrich Co, St Louis, USA while soluble 
starch (extra pure) was obtained from JT Baker 
Inc, Phillipsburg, USA. Other chemicals and 
reagents used were of analytical grade while the 
water used was glass-distilled.  
 
Preparation of plant extracts 
 
Fresh leaves of Picralima nitida were cut and 
washed under running tap to remove all foliar 
contaminants, dried at room temperature and 
pulverized to fine powder. The powdered leaves 
were divided into three portions of 50 g each and 
extracted with 500 ml each of acetone, ethanol or 
water and kept on orbital Labcon Platform shaker 
(Laboratory Consumables, PTY, Durban, South 
Africa) in covered 1000 ml flasks for 24 h at room 
temperature. The resulting infusions in each case 
was decanted, filtered and evaporated to dryness 
in a rotary evaporator (Cole Parmer SB 1100, 
Shangai, China) in respect of the organic solvent 
extracts. For the water extract, it was freeze-
dried using Virtis Bench Top freeze dryer (SP 
Scientific Series, USA). The yield was 3.99, 6.62 
and 2.41 g for acetone, ethanol and water 
extracts, respectively. The dried crude extract 
was dissolved in 10 % dimethylsulphoxide 
(DMSO) to yield a stock solution from which 
lower concentrations were prepared. 
 
Phytochemical screening  
 
The phytochemical composition of each extract 
was determined using methods variously 
described by Trease and Evans [13] and 
Sofowara [14]. 
 
Test for tannins  
 
In the test for tannins, 0.5 g of dried powdered 
sample was boiled in 20 ml of water in a test tube 
and filtered. A few drops of 0.1 % ferric chloride 
were added and observed for brownish green or 
a blue black colouration.  
 
Test for saponin  
 
Approximately 2 g of powdered material was 
boiled in 20 ml of distilled water in a water bath 
and filtered. Next, 10 ml of the filtrate was mixed 
with 5 ml of distilled water and shaken vigorously 
and observed for a stable persistent froth. The 
frothing was mixed with 3 drops of olive oil and 
shaken vigorously again and then observed for 
the formation of emulsion.  
 
Test for flavonoids  
 
A portion of the powdered material was heated 
with 10 ml of ethyl acetate over a steam bath for 
3 min. The mixture was filtered and 4 ml of the 
filtrate was shaken with 1 ml of dilute ammonia 
solution. Development of yellow colouration is an 
indication of the presence of flavonoids.  
 
Test for steroids  
 
In this test, 2 ml of acetic anhydride was added 
to 0.5 g of extract with 2 ml concentrated H2SO4. 
The colour change from violet to blue or green is 
indication of steroids. 
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Test for terpenoids  
 
In brief, 5 ml of extract (0.5 mg/ml) was mixed 
with 2 ml chloroform and 3 ml concentrated 
H2SO4 was carefully added to form a layer. A 
reddish brown colouration of the interface was 
indication of terpenoids.  
 
Test for anthraquinones  
 
5 ml of chloroform was added to 0.5 g of the 
extracts of each specimen. The resulting mixture 
was shaken for 5 min after which it was filtered. 
The filtrate was then shaken with equal volume 
of 10 % ammonia solution. The presence of a 
bright pink colour in the aqueous layer indicated 
the presence of anthraquinones. 
 
Test for reducing sugar 
 
To about 1 g of each sample in the test tube was 
added 10 ml distilled water and the mixture 
boiled for 5 min. The mixture was filtered while 
hot and the cooled filtrate made alkaline to litmus 
paper with 20 % sodium hydroxide solution. The 
resulting solution was boiled with an equal 
volume of Benedict qualitative solution on a 
water bath. The formation of a brick red 
precipitate depicted the presence of reducing 
compound. 
 
α-Amylase inhibitory assay 
 
This assay was carried out using a modified 
procedure of McCue and Shetty [15]. A total of 
250 µL of extract (1.25 – 10 mg/ml) was placed 
in a tube and 250 µL of 0.02 M sodium 
phosphate buffer (pH 6.9) containing α-amylase 
solution (0.5 mg/ml) was added. The content of 
the tubes were pre-incubated at 25 oC for 10 
mins, after which 250 µL of 1 % starch solution in 
0.02 M sodium phosphate buffer (pH 6.9) was 
added at timed intervals. The reaction mixtures 
were incubated at 25 °C for 10 min. The reaction 
was terminated by adding 500 µL of 
dinitrosalicylic acid (DNS) reagent and further 
incubated in boiling water for 5 min and cooled to 
room temperature. The content of each test tube 
was diluted with 5 ml distilled water and the 
absorbance measured at 540 nm in a 
spectrophotometer (Spectrumlab S23A, Globe 
Medical, England). A control was prepared using 
the same procedure except that the extract was 
replaced with distilled water. The α-amylase 
inhibitory activity was calculated as in Eq 1. 
% Inhibition = {(Ac – Ae)/Ac}100 …………(1) 
where Ac and Ae are the absorbance of the 
control and extract, respectively. 
The concentration of extract resulting in 50 % 
inhibition of enzyme activity (IC50) was 
determined graphically using Microsoft Excel 
2007. 
 
Mode of α-amylase inhibition 
 
The mode of inhibition of the leaf extract was 
conducted using the extract with the lowest IC50 
according to the modified method described by 
Ali et al., [16]. Briefly, 250 µL of the (5 mg/mL) 
extract was pre-incubated with 250 µL of α-
amylase solution for 10 mins at 25 ºC in one set 
of tubes. In another set of tubes, 250 µL of 
phosphate buffer (pH 6.9) was also pre-
incubated with 250 µL of α-amylase solution. 
Starch solution (250 µL) of increasing 
concentrations (0.30 – 5.0 mg/mL) was added to 
both sets of reaction mixtures to initiate the 
reaction. The mixture was then incubated for 10 
min at 25 °C, and then boiled for 5 min after 
addition of 500 µL of DNS to stop the reaction. 
The amount of reducing sugars released was 
determined spectrophotometrically using a 
maltose standard curve and converted to 
reaction velocities. A double reciprocal plot (1/v 
versus 1/[S]) where v is reaction velocity and [S] 
is substrate concentration was plotted. The type 
(mode) of inhibition of the crude extract on α-
amylase activity was determined by analysis of 
the double reciprocal (Lineweaver-Burk) plot 
using Michaelis-Menten kinetics. 
 
α-Glucosidase inhibitory assay 
 
The effect of the plant extracts on α-glucosidase 
activity was determined according to the method 
described by Kim et al., [17], using α-glucosidase 
from Saccharomyces cerevisiae. The substrate 
solution p-nitropheynyl glucopyranoside (pNPG) 
(3.0 mM) was prepared in 20 mM phosphate 
buffer, pH 6.9. 100 µL of α-glucosidase (1.0 
U/ml) was pre-incubated with 50 µL of the 
different concentrations of the extracts (acetone, 
ethanol and water) for 10 mins. Then 50 µL of 
3.0 mM (pNPG) as a substrate dissolved in 20 
mM phosphate buffer (pH 6.9) was added to start 
the reaction. The reaction mixture was incubated 
at 37 oC for 20 mins and stopped by adding 2 ml 
of 0.1 M Na2CO3. The α-glucosidase activity was 
determined by measuring the yellow colored 
para-nitrophenol released from pNPG at 405 nm. 
The results (% Inhibition) are expressed as 
percentage of the blank (control) as in Eq 2. 
% Inhibition = {(Ac – Ae)/Ac}100 …………… (2) 
where Ac and Ae are the absorbance of the 
control and extract, respectively. 
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The concentration of extract resulting in 50 % 
inhibition of enzyme activity (IC50) was 
determined graphically using Microsoft Excel. 
 
Mode of α-glucosidase inhibition 
 
The mode of inhibition of the extracts was 
determined using the extract with the lowest IC50 
according to the modified method described by 
Ali et al [16]. Briefly, 50 µL of the (5 mg/mL) 
extract was pre-incubated with 100 µL of α-
glucosidase solution for 10 mins at 25 ºC in one 
set of tubes. In another set of tubes α-
glucosidase was pre-incubated with 50 µL of 
phosphate buffer (pH 6.9). 50 µL of PNPG at 
increasing concentrations (0.63 – 2.0 mg/mL) 
was added to both sets of reaction mixtures to 
start the reaction. The mixtures were then 
incubated for 10 mins at 25 °C, and 500 µL of 
Na2CO3 was added to stop the reaction. The 
amount of reducing sugars released was 
determined spectrophotometrically using a 
paranitrophenol standard curve and converted to 
reaction velocities. A double reciprocal plot (1/v 
versus 1/[S]) where v is reaction velocity and [S] 
is substrate concentration was plotted. The type 
(mode) of inhibition of the crude extract on α-
glucosidase activity was determined by analysis 
of the double reciprocal (Lineweaver-Burk) plot 




Statistical analysis was performed using 
GraphPad Prism 5 statistical package (GraphPad 
Software, USA). The data were analysed by one-
way analysis of variance (ANOVA) followed by 
Bonferroni test. All the results were expressed as 
mean ± SE of triplicate determinations. The level 
of significance was taken at 5 % confidence 




The results obtained from the phytochemical 
screening conducted on the P. nitida leaf extracts 
are presented in Table 1.  Anthraquinone was 
absent in all the extracts while reducing sugar 
was common to all. The acetone extract contains 
only saponin and terpenoids, whereas the 
ethanol extract contains flavonoids, steroids and 
terpenoids. 
 
The inhibitory potentials of different extracts of P. 
nitida on α-amylase activity are presented on 
Figure 1. At lower concentrations (1.25 – 2.5 
mg/ml), there were no significant differences (p > 
0.05) among the values generated for all the 
extracts. However, there was significant 
difference (p < 0.05) between the percentage 
inhibition of acetone and ethanolic extract at 
concentration of 5.00 mg/ml.  When the 
concentration of the extract was increased to 10 
mg/ml, acetone extract exhibited very high 
inhibitory activity (88.39%) against α-amylase 
which is significantly different (p < 0.05) when 
compared with ethanol and aqueous extract. The 
α-amylase inhibition is dose-dependent but the 
acetone extract displayed most effective 
inhibition against α-amylase with an IC50 value of 
6.50 mg/ml (Table 2). The mode of inhibition of 
α-amylase by acetone extract of P. nitida leaf 
was determined by Lineweaver-Burke plot which 
showed that the mode of inhibition of this 
enzyme by the extract is non-competitive (Fig. 2).  
 
Table 1: Phytochemical constituents of acetone, 
ethanol and aqueous extracts of Picralima nitida 
 
 Inference  Phytochemical 
type Acetone Ethanol Water 
Anthraquinones - - - 
Flavonoids - + + 
Reducing sugar + + + 
Saponins + - + 
Steroids - + - 
Tannins - - + 
Terpenoids + + - 
                  (+) = present and (-) = not detected 
 
Table 2: IC50 values of α-amylase and α-glucosidase 
inhibition by leaf extracts of Picralima nitida 
 
               IC50 (mg/ml) Extract 
α-Amylase α-Glucosidase 
Acetone 6.50 ± 0.52 3.00 ± 0.36 
Ethanol 12.35 ± 2.05 6.15 ± 0.83 
Water 15.05 ± 1.85 7.05 ± 1.05 
 
Similar to α-amylase inhibition, there was no 
significant difference in α-glucosidase inhibition 
at lower concentrations of the extracts and the 
results.  The inhibitions of α-glucosidase by all 
the plant extracts at lower concentrations (0.63 - 
1.25 mg/mL) were not significantly different (p > 
0.05) from one another. At 2.50 mg/mL, the 
percentage inhibition of acetone and aqueous 
extract were significantly different (p < 0.05) 
when compared to ethanolic extract. The 
acetone extract displayed the highest inhibition 
(67.3 %) at the highest concentration (5.0 
mg/mL) while it was between 40.0 and 45.0 % for 
aqueous and ethanol extracts, respectively. 
Further investigation into the mode of α-
glucosidase inhibition by the plant extracts 
provided a characteristic inhibition profile in 
which acetone extract was the most potent α-
glucosidase inhibitor with an IC50 value of 3.00 
mg/ml (Table 2). The mode of inhibition of α-
glucosidase by this acetone extract of P. nitida 
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leaf was determined using Lineweaver-Burke plot 
and the plot displayed near competitive inhibition 
of the enzyme activity.  
 



























        


















Fig 1: α-Amylase inhibitory activities of Picralima nitida 
leaf extracts (a), and mode of inhibition of α-amylase 




Diabetes mellitus is a common metabolic 
disorder which may eventually lead to multiple 
organ damage and syndromes [18]. Elevated 
postprandial glucose level increases the risk of 
cardiovascular disease which is the most 
common cause of death among the people with 
diabetes. Postprandial spikes can also result into 
micro-vascular damage through oxidation of low 
density lipoprotein (LDL) and pro-atherogenic 
mechanism [19]. Management of the blood 
glucose level is a critical strategy in the control of 
diabetes and its complications. 
 
Diet rich in carbohydrate causes sharp rise in the 
blood glucose level as the complex carbohydrate 
in food is rapidly absorbed in the intestine aided 
by the α-amylase and α-glucosidase enzyme 
which break carbohydrate to simple absorbable 
sugars (monosaccharides) [19]. Inhibitors of 
saccharide hydrolyzing enzymes (α-amylase and 
α-glucosidase) have been useful as oral 
hypoglycemic drugs for the control of 
hyperglycemia especially in patients with Type II 
diabetes mellitus [20]. These inhibitors delay 
carbohydrate digestion and prolong overall 
carbohydrate digestion time causing reduction in 
the rate of glucose absorption and consequently 
reducing the post prandial plasma glucose rise 
[21].  
 











































Fig 2: α-Glucosidase inhibitory activity of Picralima 
nitida leaf extracts (a), and mode of inhibition of α-
glucosidase by acetone extract of Picralima nitida leaf 
(b) 
 
Synthetic hypoglycemic drugs like acarbose, 
miglitol and voglibose are used in conjunction 
with other antidiabetic drugs, but these inhibitors 
have been found to possess gastrointestinal side 
effects like abdominal discomfort, flatulence and 
diarrhoea. As a result of this, there is growing 
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amylase and α-glucosidase inhibitors from plants 
with minimal or no side effects [22]. 
 
In the present study, the acetone extract showed 
the most potent inhibition of α-amylase activity at 
all concentrations tested. However, at high 
concentration (10.00 mg/ml), the inhibition was 
strong which is undesirable of α-amylase 
inhibitor. This was also attested to by the high 
IC50 for the α-amylase inhibition. In order for 
hypoglycemic agents to elicit their 
pharmacological effects and prevent the side 
effects experienced with the use of synthetic 
drugs, medicinal plants should be mild inhibitors 
of α-amylase [19]. To determine the mode of 
inhibition of this enzyme, the double reciprocal 
plot indicated a non-competitive inhibition of α-
amylase by P. nitida extracts. This suggests that 
the active component of the extract binds to a 
site other than the active site of the enzyme and 
combine with either free enzyme or enzyme-
substrate complex possibly interfering with the 
action of both [23].  
 
The in vitro α-glucosidase inhibitory results 
demonstrated that all the extracts of P. nitida leaf 
possess α-glucosidase inhibitory activities. 
However, acetone extract exhibited the strongest 
inhibition of the enzyme as attested to by the 
lowest IC50 generated. This is in agreement with 
previous reports that phytochemicals from plants 
are strong inhibitors of α-glucosidase [19]. The 
curve generated from the Lineweaver-Burke plot 
of this inhibition showed a near competitive mode 
of inhibition of the α-glucosidase. This implies the 
active components of the extract compete with 
the substrate for binding to the active site of the 
enzyme, thereby preventing or slowing down the 
breakdown of oligosaccharides to disaccharides 
[22]. The phytochemical screening revealed the 
presence of saponins and terpenoids. The 
inhibitory effect of the extracts of P. nitida may 
not be unconnected with the presence of 




Although the acetone extract exhibited the most 
potent α-amylase and α-glucosidase inhibitory 
activity which is an indication that the solvent is 
capable of extracting the active constituents in P. 
nitida, the use of infusion and decoction is to be 
encouraged for a mild to moderate activity since 
a higher dosage of the alcohol extract can lead to 
undesirable α-amylase and α-glucosidase 
inhibitory effects in humans. The inhibitory effect 
of these extracts on both enzymes may be linked 
to the presence of saponins and terpenoids 
which may be acting individually or in synergy. 
This study further validates the folkloric use of P. 
nitida in the management of sugar related 
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